Journal Rank: CiteScore 1.8 - Q3 (Cardiology and
Cardiovascular Medicine)
Median time to first editorial decision: 8 days

Vessel Plus

Articles

Most Recent | Most Viewed | Most Downloaded

Prussian blue nanozyme for ischemia-reperfusion injury treatment: progress, opportunities and challenges

Open Access Review DOI: 10.20517/2574-1209.2025.172 25 May 2026
Views: Downloads:
Download PDF

The potential value of long non-coding RNA in molecular diagnosis and forensic identification of heart failure

Open Access Review DOI: 10.20517/2574-1209.2025.142 25 May 2026
Views: Downloads:
Download PDF

Circular RNAs: key orchestrators of pathological remodeling in heart failure

Open Access Review DOI: 10.20517/2574-1209.2026.01 24 May 2026
Views: Downloads:
Download PDF

Panvascular aging as a unifying framework: convergent mechanisms across age-related diseases

Open Access Review DOI: 10.20517/2574-1209.2025.120 17 May 2026
Views: Downloads:
Download PDF

The role of microRNAs in acute and chronic heart failure: a key regulator and therapeutic target

Open Access Review DOI: 10.20517/2574-1209.2025.167 14 May 2026
Views: Downloads:
Download PDF

Role of inflammation in the progression of diabetic kidney disease

Open Access Review DOI: 10.20517/2574-1209.2024.21 10 Jul 2024
Views: Downloads:
Download PDF

Non-atherosclerotic coronary artery disease in molecular autopsy: a literature review

Open Access Review DOI: 10.20517/2574-1209.2024.57 26 Apr 2025
Views: Downloads:
Download PDF

The role of inflammatory response in the development of atherosclerosis, myocardial infarction, and remodeling

Open Access Review DOI: 10.20517/2574-1209.2024.14 26 Aug 2024
Views: Downloads:
Download PDF

Coming soon.

On September 19, 2025, Stanford University and Elsevier jointly released the World’s Top 2% Scientists 2025 list. We are proud to announce that 32 members of the Vessel Plus Editorial Board have been recognized among the world’s leading scientists.
Vessel Plus has received its first official Impact Factor of 0.7, as announced in the 2025 Journal Citation Reports (JCR) by Clarivate on June 18, 2025. The journal is ranked 200th out of 230 journals in the Cardiac & Cardiovascular Systems category and is classified in Q4.
As Editor-in-Chief of JACC, Prof. Krumholz champions research with genuine clinical and societal impact. He promotes inclusivity, innovation, open science, and data ethics, and calls for transparent, accountable systems that empower patients and foster equitable progress in cardiovascular medicine.
Prof. Crea shares his editorial approach, views on the impact of emerging technologies, and perspectives on the future of academic publishing and medical leadership. The interview was conducted by Prof. Aijun Sun, Editor-in-Chief of Vessel Plus.
Vessel Plus is seeking passionate young scholars from around the world to join its Youth Editorial Board for a two-year term.
Application Deadline: June 30, 2025.

Coming soon.

Vessel Plus
ISSN 2574-1209 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/